5 months AbbVie lifts profit forecast after Skyrizi sales beat expectations Yahoo Finance AbbVie lifts profit forecast after Skyrizi sales beat expectations. AbbVie (ABBV)
2 weeks Bausch Reportedly Explores A Sale; Could Alcon, J&J Or AbbVie Buy It?Investor's Business Daily
2 weeks The Zacks Analyst Blog Highlights Visa, AbbVie, Anheuser-Busch, Servotronics and United-GuardianZacks
1 month Abbvie (ABBV) has been the biggest surprise in my portfolio, up 22% YTD with a 3% div. What’s been a surprise stock in your portfolio?Reddit
1 month 3 High-Yield Stocks to Buy Now That Have Increased Their Dividends for 25 Years or MoreThe Motley Fool
2 months AbbVie Inc. (ABBV): Among the Best Cosmetic Surgery and Aesthetics Stocks To Buy NowInsider Monkey
2 months AbbVie Is About To Have A New Golden Goose As Humira Sales Continue SlowingInvestor's Business Daily
2 months AbbVie Could Soar 24%, According to a Wall Street Analyst. Is the High-Yield Dividend Stock a Buy Now?The Motley Fool
4 months AbbVie, Inc. (ABBV) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript)Seeking Alpha
4 months Is AbbVie Inc. (NYSE:ABBV) the Most Undervalued Dividend Aristocrat Stock According to Analysts?Insider Monkey
4 months 1 Wall Street Analyst Thinks AbbVie Stock Is Going to $200. Is It a Buy at Around $165?The Motley Fool
5 months Unveiling AbbVie’s Winning Strategy In Pharmaceutical Innovation (Rating Upgrade)Seeking Alpha
5 months AbbVie Is ‘Firing On All Cylinders,’ But Its Stock Doesn’t Show ThatInvestor's Business Daily